These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 19035462)

  • 1. Characterization of a glycine N-methyltransferase gene knockout mouse model for hepatocellular carcinoma: Implications of the gender disparity in liver cancer susceptibility.
    Liao YJ; Liu SP; Lee CM; Yen CH; Chuang PC; Chen CY; Tsai TF; Huang SF; Lee YH; Chen YM
    Int J Cancer; 2009 Feb; 124(4):816-26. PubMed ID: 19035462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of the glycine N-methyltransferase gene leads to steatosis and hepatocellular carcinoma in mice.
    Martínez-Chantar ML; Vázquez-Chantada M; Ariz U; Martínez N; Varela M; Luka Z; Capdevila A; Rodríguez J; Aransay AM; Matthiesen R; Yang H; Calvisi DF; Esteller M; Fraga M; Lu SC; Wagner C; Mato JM
    Hepatology; 2008 Apr; 47(4):1191-9. PubMed ID: 18318442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatoma cells from mice deficient in glycine N-methyltransferase have increased RAS signaling and activation of liver kinase B1.
    Martínez-López N; García-Rodríguez JL; Varela-Rey M; Gutiérrez V; Fernández-Ramos D; Beraza N; Aransay AM; Schlangen K; Lozano JJ; Aspichueta P; Luka Z; Wagner C; Evert M; Calvisi DF; Lu SC; Mato JM; Martínez-Chantar ML
    Gastroenterology; 2012 Sep; 143(3):787-798.e13. PubMed ID: 22687285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher susceptibility to aflatoxin B(1)-related hepatocellular carcinoma in glycine N-methyltransferase knockout mice.
    Liu SP; Li YS; Lee CM; Yen CH; Liao YJ; Huang SF; Chien CH; Chen YM
    Int J Cancer; 2011 Feb; 128(3):511-23. PubMed ID: 20473876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycine N-methyltransferase tumor susceptibility gene in the benzo(a)pyrene-detoxification pathway.
    Chen SY; Lin JR; Darbha R; Lin P; Liu TY; Chen YM
    Cancer Res; 2004 May; 64(10):3617-23. PubMed ID: 15150120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
    Frau M; Feo F; Pascale RM
    J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycine N-methyltransferase affects the metabolism of aflatoxin B1 and blocks its carcinogenic effect.
    Yen CH; Hung JH; Ueng YF; Liu SP; Chen SY; Liu HH; Chou TY; Tsai TF; Darbha R; Hsieh LL; Chen YM
    Toxicol Appl Pharmacol; 2009 Mar; 235(3):296-304. PubMed ID: 19146867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A DNA methylation signature associated with the epigenetic repression of glycine N-methyltransferase in human hepatocellular carcinoma.
    Huidobro C; Toraño EG; Fernández AF; Urdinguio RG; Rodríguez RM; Ferrero C; Martínez-Camblor P; Boix L; Bruix J; García-Rodríguez JL; Varela-Rey M; Mato JM; Martínez-Chantar ML; Fraga MF
    J Mol Med (Berl); 2013 Aug; 91(8):939-50. PubMed ID: 23475283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotypic and phenotypic characterization of a putative tumor susceptibility gene, GNMT, in liver cancer.
    Tseng TL; Shih YP; Huang YC; Wang CK; Chen PH; Chang JG; Yeh KT; Chen YM; Buetow KH
    Cancer Res; 2003 Feb; 63(3):647-54. PubMed ID: 12566309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the GNMT-HectH9-PREX2 tripartite relationship in the pathogenesis of hepatocellular carcinoma.
    Li CH; Yen CH; Chen YF; Lee KJ; Fang CC; Zhang X; Lai CC; Huang SF; Lin HK; Arthur Chen YM
    Int J Cancer; 2017 May; 140(10):2284-2297. PubMed ID: 28205209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of FKBP11 as a biomarker for hepatocellular carcinoma.
    Lin IY; Yen CH; Liao YJ; Lin SE; Ma HP; Chan YJ; Chen YM
    Anticancer Res; 2013 Jun; 33(6):2763-9. PubMed ID: 23749938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of 1,2,3,4,6-Penta-O-galloyl-β-d-glucopyranoside as a Glycine N-Methyltransferase Enhancer by High-Throughput Screening of Natural Products Inhibits Hepatocellular Carcinoma.
    Kant R; Yen CH; Lu CK; Lin YC; Li JH; Chen YM
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27153064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene Expression and DNA Methylation Alterations in the Glycine N-Methyltransferase Gene in Diet-Induced Nonalcoholic Fatty Liver Disease-Associated Carcinogenesis.
    Borowa-Mazgaj B; de Conti A; Tryndyak V; Steward CR; Jimenez L; Melnyk S; Seneshaw M; Mirshahi F; Rusyn I; Beland FA; Sanyal AJ; Pogribny IP
    Toxicol Sci; 2019 Aug; 170(2):273-282. PubMed ID: 31086990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of Methionine Cycle Genes
    Chen PM; Tsai CH; Huang CC; Hwang HH; Li JR; Liu CC; Ko HA; Chiang EI
    Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional characterization of glycine N-methyltransferase and its interactive protein DEPDC6/DEPTOR in hepatocellular carcinoma.
    Yen CH; Lu YC; Li CH; Lee CM; Chen CY; Cheng MY; Huang SF; Chen KF; Cheng AL; Liao LY; Lee YH; Chen YM
    Mol Med; 2012 Mar; 18(1):286-96. PubMed ID: 22160218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficiency of glycine N-methyltransferase results in deterioration of cellular defense to stress in mouse liver.
    Liao YJ; Chen KH; Huang SF; Chen TL; Wang CK; Chien CH; Tsai TF; Liu SP; Chen YM
    Proteomics Clin Appl; 2010 Apr; 4(4):394-406. PubMed ID: 21137059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor suppressor gene glycine N-methyltransferase and its potential in liver disorders and hepatocellular carcinoma.
    Chen M; Yang MH; Chang MM; Tyan YC; Chen YA
    Toxicol Appl Pharmacol; 2019 Sep; 378():114607. PubMed ID: 31170416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of glycine-N-methyltransferase-gene expression in human hepatocellular carcinoma.
    Chen YM; Shiu JY; Tzeng SJ; Shih LS; Chen YJ; Lui WY; Chen PH
    Int J Cancer; 1998 Mar; 75(5):787-93. PubMed ID: 9495250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of GNMT by 1,2,3,4,6-penta-O-galloyl-beta-D-glucopyranoside through proteasome-independent MYC downregulation in hepatocellular carcinoma.
    Kant R; Yen CH; Hung JH; Lu CK; Tung CY; Chang PC; Chen YH; Tyan YC; Chen YA
    Sci Rep; 2019 Feb; 9(1):1968. PubMed ID: 30760754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel role of the tumor suppressor GNMT in cellular defense against DNA damage.
    Wang YC; Lin WL; Lin YJ; Tang FY; Chen YM; Chiang EP
    Int J Cancer; 2014 Feb; 134(4):799-810. PubMed ID: 23922098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.